Heavy rains throw life out of gear across coastal Karnataka

Bengaluru, July 14: Girls outshone boys in the Second Pre-University Board examinations in Karnataka, results of which were announced on Tuesday.

As many as 6.75 lakh students had written the examination of which 4.17 lakh students passed.

Thus, the pass percentage is 61.80 per cent, Primary and Secondary Education Minister S Suresh Kumar said while announcing the results.

He said 68.73 per cent girls cleared the exam against the boys whose pass percentage was 54.77 per cent.

In terms of urban versus rural, 62.60 per cent students passed in the urban area while 58.99 per cent were from rural areas.

The three districts where the students' performance was excellent were Udupi, Dakshina Kannada and Kodagu whereas the districts where students fared badly were Chitradurga, Raichur and Vijayapura, the minister said.

Both Dakshina Kannada and Udupi have recorded 90.71 percent results. Kodagu has bagged second position with 81.53 pass percentage. Vijayapura district has recorded lowest pass percentage (54.22)

Combination wise, the pass percentage of students in science stream is 82.57 per cent, Commerce 72.60 per cent and Arts 47.90 per cent, said the Minister.

He also said of those who passed the examination, 72. 45 per cent were from English medium and 47.56 from Kannada medium.

There are 68,866 distinction scorers, 2,21,866 students who got first division and 77,455 students who passed the exam in second division, the minister added.

Bantwal, Jun 16: Two unmarred siblings committed suicide by self-immolation at Sangabettu in Bantwal taluk of Dakshina Kannada last night.

Neelayya Shettogar (42) and his sister Kesari (39) poured petrol on themselves before torching themselves at around 11 p.m. on June 15 inside a room of their house, police sources said. The siblings were reportedly facing health problems.

Neelayya's brother and latter’s wife were sleeping in the other room of the same house when the incident took place. They came to know only when they heard the screams of the duo.

Even though the siblings were rushed to the government hospital at Bantwal with the help of locals, the doctors declared them dead.

Bantwal rural police sub-inspector, Prasanna and staff visited the spot as part of investigation.

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.